Showing results (1551-1560 of 1,621) with videos related to
Sort By:
Pageof 163
Biomaterials|October 17, 2024
PAR<sub>2</sub> on oral cancer cells and nociceptors contributes to oral cancer pain that can be relieved by nanoparticle-encapsulated AZ3451Divya Bhansali, Nguyen H Tu, Kenji Inoue, et al.Proceedings of the National Academy of Sciences of the United States of America|February 3, 2022
Mice expressing fluorescent PAR<sub>2</sub> reveal that endocytosis mediates colonic inflammation and painRocco Latorre, Alan Hegron, Chloe J Peach, et al.Biomaterials|May 9, 2022
Sustained endosomal release of a neurokinin-1 receptor antagonist from nanostars provides long-lasting relief of chronic painRocco Latorre, Paulina D Ramírez-Garcia, Alan Hegron, et al.Pediatric Neurology|June 10, 2021
Further Delineation of the Clinical and Pathologic Features of HIKESHI-Related Hypomyelinating LeukodystrophyGuy Helman, Ayelet Zerem, Akshata Almad, et al.Cancers|May 15, 2018
A New Strategy to Control and Eradicate "Undruggable" Oncogenic K-RAS-Driven Pancreatic Cancer: Molecular Insights and Core Principles Learned from Developmental and Evolutionary BiologyRobert E Van Sciver, Michael P Lee, Caroline Dasom Lee, et al.Archives of Pathology & Laboratory Medicine|December 14, 2016
Statistical Literacy Among Academic Pathologists: A Survey Study to Gauge Knowledge of Frequently Used Statistical Tests Among Trainees and FacultyRobert L Schmidt, Deborah J Chute, Jorie M Colbert-Getz, et al.Science (New York, N.Y.)|September 5, 2024
Achieving optical transparency in live animals with absorbing moleculesZihao Ou, Yi-Shiou Duh, Nicholas J Rommelfanger, et al.Cell Host & Microbe|September 27, 2025
A Bacteroides fragilis protease activates host PAR<sub>2</sub> to induce intestinal pain and inflammationMarkus Lakemeyer, Rocco Latorre, Kristyna Blazkova, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 11, 2020
Legumain Induces Oral Cancer Pain by Biased Agonism of Protease-Activated Receptor-2Nguyen Huu Tu, Dane D Jensen, Bethany M Anderson, et al.Clinical Genitourinary Cancer|August 9, 2022
CABOSEQ: The Effectiveness of Cabozantinib in Patients With Treatment Refractory Advanced Renal Cell Carcinoma: Results From the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC)Vishal Navani, J Connor Wells, Devon J Boyne, et al.Pageof 163